
|Videos|January 13, 2015
How New Regulatory Requirements Have Affected Controlled Dangerous Substance Dispensing
Karen Ryle, MS, RPh, associate chief of pharmacy at Massachusetts General Hospital, discusses how new regulatory requirements have affected controlled dangerous substance dispensing.
Advertisement
Karen Ryle, MS, RPh, associate chief of pharmacy at Massachusetts General Hospital, discusses how new regulatory requirements have affected controlled dangerous substance dispensing.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Guiding Patients With Sickle Cell Disease Through the Transformative Era of Gene Therapy
2
New Data Highlights Pharmacists’ Expanding Roles in Hematologic Malignancies
3
Bridging Response Emerges as Key Predictor of Cilta-Cel Outcomes in CARTITUDE-4
4
Deeper MRD Responses Strengthen Shared Decision-Making as Daratumumab Use Expands Across Treatment Phases
5


















































































































































































































